英文别名(2R,5S)-5-(4-Fluorophenyl)-2-[(S)-[(4-fluorophenyl)amino](4-hydroxyphenyl)methyl]-5-hydroxypentanoic acid; Ezetimibe Azetidinone Ring-opened Impurity; (2R,5S)-2-[(S)-(4-fluoroanilino)-(4-hydroxyphenyl)methyl]-5-(4-fluorophenyl)-5-hydroxypentanoic acid; Ezetimibe Impurity 19; Ezetimibe Azetidinone Ring opened impurity; Ezetimibe Open-Ring Acid; Ezetimibe Impurity 138(Azetidinone Ring-Opened Impurity); (2R,5S)-2-[(S)-(4-Fluorophenylamino)(4-hydroxyphenyl)methyl]-5-(4-fluorophenyl)-5-hydroxyvaleric acid; (2R,5S)-5-(4-Fluorophenyl)-2-[(S)-[(4-fluorophenyl)amino](4-hydroxyphenyl)methyl]-5-hydroxypentanic acid; (alphaR,deltaS)-4-Fluoro-alpha-[(S)-[(4-fluorophenyl)amino](4-hydroxyphenyl)methyl]-delta-hydroxybenzenepentanoic acid; Benzenepentanoic acid, 4-fluoro-alpha-[(S)-[(4-fluorophenyl)amino](4-hydroxyphenyl)methyl]-delta-hydroxy-, (alphaR,deltaS)-; Rel-(2R,5S)-5-(4-fluorophenyl)-2-((S)-((4-fluorophenyl)amino)(4-hydroxyphenyl)methyl)-5-hydroxypentanoic acid; Ezetimibe Impurity 56 
